FindTrial
Sign In

Study of causes of exudative pleural effusion with ADA values between 40 and 60 in the department of pulmonary medicine, IGMC, Shimla, Himachal Pradesh.

An Etiopathological profile of patients with exudative pleural effusion having ADA levels between 40-60 in the department of pulmonary medicine, IGMC,Shimla ,Himachal Pradesh

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/12/060741
Enrollment
40
Registered
2023-12-26
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J918- Pleural effusion in other conditions classified elsewhere

Interventions

Control Intervention1: NIL: NIL

Sponsors

DR RS NEGI
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age, more than 18 years.. 2. Undiagnosed exudative pleural effusion. 3. ADA between 40 and 60

Exclusion criteria

Exclusion criteria: 1. Respiratory insufficiency, with hypoxemia and hypercapnia 2. Severe chronic obstructive pulmonary disease 3. Pleural thickening of unknown etiology 4. Suspected mesothelioma where the visceral and parietal surfaces fuse 5. Previous pleurodesis 6. Unstable cardiovascular status 7. Known primary malignancy 8. Pleural adhesions 9. Transudative pleural effusion 10. coagulation defects/bleeding diathesis/thrombocytopenia 11. Drug hypersensitivity 12. Severe pulmonary fibrosis. 13. Patient on anticoagulant therapy 14. Inability to lie in lateral decubitus position

Design outcomes

Primary

MeasureTime frame
1.To describe the etiopathological profile of the patients with exudative pleural effusion with ADA levels 40-60 at a tertiary care Centre, IGMC ShimlaTimepoint: Each samples outcome will be recorded in 2 weeks in case of biopsy specimen and 1day in case of CBNAAT specimen with respect to resource constraint—

Secondary

MeasureTime frame
.To describe the etiopathological profile of the patients with exudative pleural effusion with ADA levels 40-60 at a tertiary care Centre, IGMC ShimlaTimepoint: The final collection of result will be recorded at the end of the trial i.e after 10months for the final compilation of data—

Countries

India

Contacts

Public ContactGAUTAM PREM

IGMC

drrsnegi@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026